Valproic acid Completed Phase 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00136110Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis